Business

In a surprising turn of events, Paramount Global has decided to dismantle a significant portion of its diversity, equity, and inclusion (DEI) initiatives, moving in alignment with a directive from the Trump administration. This shift raises questions not only about the company’s long-term commitment to inclusivity but also signals broader implications for corporate America. The

In a spirited effort to retain investor confidence and ensure a steady stream of income amidst fluctuating market conditions, General Motors (GM) has recently announced a significant increase to its quarterly dividend. This decision, coupled with the initiation of a robust $6 billion share repurchase program, underscores GM’s commitment to rewarding shareholders even in the

Eli Lilly has unveiled a strategic shift in the distribution of its weight loss medication, Zepbound, aimed at increasing accessibility for patients, particularly those without insurance coverage. By releasing higher doses in single-dose vials at a substantially reduced price, Lilly is making efforts to broaden access to this breakthrough treatment in a landscape where demand

The inefficiency of the U.S. government has long been a topic of discussion among business leaders, economists, and politicians. Recently, Jamie Dimon, the CEO of JPMorgan Chase, brought this issue to the forefront during a conversation with CNBC’s Leslie Picker. He expressed concerns about a government that he perceives as lacking in competence and needing

UnitedHealthcare, the nation’s largest private insurer, is navigating a stormy maritime of challenges, from an impending government investigation of its Medicare billing practices to potential layoffs. These recent developments mark a continuation of UnitedHealth Group’s rocky trajectory over the past year, compounded by high-profile incidents, including the tragic death of a top executive and a

In a significant turn of events for the pharmaceutical landscape, the U.S. Food and Drug Administration (FDA) announced the resolution of the long-standing shortage of semaglutide-based drugs, Wegovy and Ozempic. After more than two arduous years marked by escalating demand and lost accessibility, the FDA’s confirmation not only reverberates through the healthcare community but also

Bluebird Bio’s recent decision to sell itself to private equity firms Carlyle and SK Capital for a mere $30 million underscores the precarious nature of the biotechnology sector, particularly for firms that once held immense promise. This precipitous decline, from high-flying biotech innovator to a company struggling to maintain its financial viability, serves not just

The Air Force One project has encountered numerous challenges, particularly under the Trump administration, leading to extensive delays and budget overruns. Negotiations surrounding the $4 billion contract for two new Boeing 747s have become a public concern, highlighting the complexities inherent in large government contracts and Boeing’s recent operational difficulties. The anticipation of new Air

In a significant move, KFC, the iconic fried chicken chain, is set to relocate its U.S. headquarters from Louisville, Kentucky, to Plano, Texas. This decision, disclosed by Yum Brands on Tuesday, marks a pivotal shift in the company’s operational strategy, aligning with the growing trend of corporations reassessing their headquarters in response to shifting dynamics

Sickle cell disease, a genetic blood disorder primarily affecting individuals of African descent, creates significant health challenges, notably severe pain episodes and hospitalizations. For adolescents like Deshawn “DJ” Chow, living with this condition often means confronting the possibility of an uncertain future. At just 19 years old, the cycle of pain and care led DJ